Plasma 25-hydroxyvitamin D and risk of pancreatic cancer. - Wikidata - awgldk - TriplyDB

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

http://www.wikidata.org/entity/Q35661250

about

Molecular link between vitamin D and cancer prevention Do studies reporting 'U'-shaped serum 25-hydroxyvitamin D-health outcome relationships reflect adverse effects?The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma Dairy products and pancreatic cancer risk: a pooled analysis of 14 cohort studies Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L Clinical Management of Pancreatic Cancer The roles of UVB and vitamin D in reducing risk of cancer incidence and mortality: A review of the epidemiology, clinical trials, and mechanisms.Environmental risk factors for pancreatic cancer: an update.Randomized controlled trials of vitamin D and cancer incidence: A modeling study.Murine Pancreatic Acinar Cell Carcinoma Growth Kinetics Are Independent of Dietary Vitamin D Deficiency or Supplementation.Vitamin D for health: a global perspective Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy.Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.Vitamin D and GI cancers: shedding some light on dark diseases The vitamin D system is deregulated in pancreatic diseases Vitamin D transport proteins megalin and disabled-2 are expressed in prostate and colon epithelial cells and are induced and activated by all-trans-retinoic acid Risk factors for pancreatic cancer: a summary review of meta-analytical studies.Genetic variants in vitamin d pathway genes and risk of pancreas cancer; results from a population-based case-control study in ontario, Canada.Vitamin D metabolic pathway genes and pancreatic cancer risk.Vitamin D-binding protein and pancreatic cancer: a nested case-control study.Vitamin D and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Case-Control Consortium.Vitamin D and Cancer: Diversity, Complexity, and Still a Ways to Go Dietary supplements and cancer prevention: balancing potential benefits against proven harms.Serum 25-Hydroxyvitamin D Concentrations ≥40 ng/ml Are Associated with >65% Lower Cancer Risk: Pooled Analysis of Randomized Trial and Prospective Cohort Study.Effect of follow-up time on the relation between prediagnostic serum 25-hydroxyvitamin D and all-cause mortality rate.Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer.The problems of vitamin d insufficiency in older people.Plasma 25-hydroxyvitamin D(3) and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study.A prospective study of plasma adiponectin and pancreatic cancer risk in five US cohorts.Retrospective analysis of the influence of 25-hydroxyvitamin D on disease progression and survival in pancreatic cancer.Prospective analysis of vitamin D and endometrial cancer risk.Circulating Metabolites and Survival Among Patients With Pancreatic Cancer Hyperglycemia, insulin resistance, impaired pancreatic β-cell function, and risk of pancreatic cancer.Prediagnostic Plasma 25-Hydroxyvitamin D and Pancreatic Cancer Survival Vitamin D deficiency and prognostics among patients with pancreatic adenocarcinoma.Vitamins in pancreatic cancer: a review of underlying mechanisms and future applications.Targeting Transcriptional and Epigenetic Reprogramming in Stromal Cells in Fibrosis and Cancer.Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer.

P2860

Q24602044-EF372AC6-86EE-47BF-93AD-83EA1FD7DB96 Q26739511-A143E0AC-A0F2-43F0-B393-64E41B243FE3 Q26748470-0C93AF27-2C1A-4AF5-8774-7BD38BFA64BC Q26780372-0D2A72D9-D20F-461B-AE1B-82572A73F2BC Q26801418-41A2E220-12E6-4796-A73D-413A9E02B34B Q26996384-81FE9788-78FF-4615-9237-28B809641597 Q28069109-C145FED2-478C-455F-93A0-1B5B6A565E4A Q28084173-04E38921-9032-4825-9DD4-7AF91B04D96C Q30235880-0E8EDC93-D155-4AF7-8D69-9598BAFAA0A4 Q30248417-10D82582-D879-4DF0-95AC-290CF72CE75B Q33620889-59726459-6571-4A29-A8DC-2ACFE97963C5 Q33845341-37723327-5301-4AAF-8A88-8D013072913D Q34037261-68A75259-78AD-4374-B2F3-456F0DAA4501 Q34253198-C61469E8-C865-451F-8DC5-DBC5652B636E Q34315320-991499A5-49D5-49AA-95CB-0B55912624A7 Q34357880-54A6C4F9-7611-4CBA-9B4F-5C397D7B4BEA Q34440700-4A99D6B4-9FE3-45FA-B1C7-AF1CDD722D6F Q34541761-4EB4A2C4-3D62-4945-A904-AD87FA5D3997 Q34667061-BDEE1764-05B8-4F77-9433-3DF7F1D82F59 Q34795962-C69A9B6A-F977-4D09-8D8E-D660C40300E3 Q35208726-98CE28C4-09A6-4D68-93AE-D65BDCF91EF7 Q35638739-C2438AB5-EB08-4622-87A7-E97C3F86F15A Q35879075-440092A7-7DD2-491E-BA96-CB1171825AB1 Q35925081-E5DA716E-15C8-44E6-9115-242858C4C31E Q35962084-3FCE25C0-4250-433D-AED5-DE6EB8484CB5 Q35980745-89CFE622-FE4E-4B33-961D-FCF93475CE9D Q36187638-7E88511F-FD3F-465B-9499-2C2E2AF67C24 Q36279579-D5DBA0B0-D4D8-4C36-9E80-8BE3D32C38E8 Q36409061-A223A326-93C7-494A-8BA3-B2E2B6B4B374 Q36476562-64FC73BB-9850-47CF-8AC1-573C6E5CB888 Q36535684-78DC6B12-F15D-496C-82F4-17EC59D5E5C5 Q36574978-C47142A7-54AD-4680-83E2-58F66B7FEA71 Q36615761-21A50978-9ACD-4704-8417-B91BD40FEF93 Q36848069-0EC6BD71-7075-4D8D-80F1-6C7BB5645CC0 Q37021217-153E6BBA-AD3C-4E22-8D22-7AAC84B77367 Q37234780-9C96572D-8BA2-44F7-BB6E-A65CF0A9017B Q37351839-6ED7F4B4-26C4-414B-B857-502E83650ACF Q38633074-3AEDA948-3374-4DB9-8DE9-3F32CCF2FAEE Q38708376-8934FDAD-0B14-4428-8636-BBC359B35161 Q38794281-063FFF8B-D452-436E-8549-3A9C29DF3203

P2860

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

http://www.wikidata.org/entity/Q35661250

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@ast

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@en

type

label

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@ast

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@en

prefLabel

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@ast

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@en

P1433

Q35661250-3B673888-6D0A-4F6B-A4B4-F60C65FC6DC8

P1476

Q35661250-260BF923-50E6-4114-816C-D15768393D5C

P2093

Q35661250-12C82B00-29E6-4AD0-9DB7-B68D661A9289

Q35661250-207D73D4-ADEF-40A0-84C2-DB2DE506619A

Q35661250-2E6CDAB5-F6B2-43B3-B17B-68B9240E2E77

Q35661250-42EF9585-34C6-4ECC-8DBA-8C81B4BC8311

Q35661250-79885CBD-7EEC-49E4-9919-26E612C58E0D

Q35661250-84A85B24-9EC5-4F44-B14D-4C42C32D4E02

Q35661250-A2A0DD27-E15C-4693-A4E7-001B6E90ED58

Q35661250-A8D5D745-169B-4DA0-B90B-DD455A46CEB9

Q35661250-CA4A4149-B8E9-4158-BB8C-19FFFE68FB70

Q35661250-D5D13A6D-4AA9-4106-B587-6415A087DF2E

P2860

Q35661250-06EAE170-36A5-49F0-8493-E96C55FC2FB3

Q35661250-0814E469-E550-4160-9A5C-879574C4BCA4

Q35661250-0A93AED2-6868-4D51-9AEE-B7130E4DE03F

Q35661250-14DF0C67-817A-44A0-BF88-23AB10E6FB33

Q35661250-15E85F4D-7BCD-4098-9A5E-5E7E97399298

Q35661250-251E862F-DF96-4548-84F3-B6F7CCA3880F

Q35661250-2E00C248-B324-4C56-B7AB-B76BACE29B2C

Q35661250-35D70AA1-0B6E-4110-B0D3-769E3A6E4887

Q35661250-3F5272A5-C0FA-429C-8FBB-24F1FA593B0E

Q35661250-40721C54-6F58-4321-ACD1-07E4CC303CC4

P304

Q35661250-E18DBD3A-F518-4D16-A403-AB80CC2C77CC

P31

Q35661250-1383CC47-E9D3-411F-95D2-7A26265D4C93

P356

Q35661250-FA9E0077-E9A3-48E6-9773-63834CA0D986

P433

Q35661250-10AAFFF5-52E0-436B-9A32-7AE1088128BA

P478

Q35661250-85A05B7C-E9E7-4341-ACA5-2BFAAA6C1E82

P50

Q35661250-047B54E2-B142-4EB2-8961-EB48CBA144C6

Q35661250-1AE2F85C-F753-4C74-833A-9E1F6813CEC8

Q35661250-4BA057A1-EE6F-4CD1-ACFB-5DD54BFE9FD7

Q35661250-6FD9CCD7-9105-4F77-9CFA-BF836410958B

Q35661250-7D9455B9-C79A-4B3D-AC6C-8034F1F99B84

Q35661250-AF7132CE-B7FF-4AE9-A777-4F47C45311AE

Q35661250-C502663D-41AC-4D3D-809D-7E8BCFA5AE45

Q35661250-FF7DC5F2-DB63-4ED6-9694-83B4A454EA5E

P577

Q35661250-07D9AE93-1D63-44DD-8831-BADF14F2B9A4

P698

Q35661250-6EC157A5-9468-4440-92E5-2F1D36B23A53

P932

Q35661250-85A8E42B-C8D3-48C4-B4E8-78D8C7A6F34A

P356

1055-9965.EPI-11-0836

P1433

Cancer Epidemiology, Biomarkers & Prevention

P1476

Plasma 25-hydroxyvitamin D and risk of pancreatic cancer.

@en

P2093

Barbara B Cochrane

http://www.w3.org/2001/XMLSchema#string

Brian M Wolpin

http://www.w3.org/2001/XMLSchema#string

Dominique S Michaud

http://www.w3.org/2001/XMLSchema#string

Howard D Sesso

http://www.w3.org/2001/XMLSchema#string

I-Min Lee

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

JoAnn E Manson

http://www.w3.org/2001/XMLSchema#string

Kimmie Ng

http://www.w3.org/2001/XMLSchema#string

Rowan T Chlebowski

http://www.w3.org/2001/XMLSchema#string

Ying Bao

http://www.w3.org/2001/XMLSchema#string

P2860

Prospective Study of Predictors of Vitamin D Status and Cancer Incidence and Mortality in Men

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know

Noncalcemic Actions of Vitamin D Receptor Ligands

Vitamin D deficiency

Meta-analysis in clinical trials

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial

Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study

Reproducibility and validity of a semiquantitative food frequency questionnaire

C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus

P304

82-91

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1055-9965.EPI-11-0836

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P50

Edward Giovannucci

Jean Wactawski-Wende

Julie E. Buring

Meir J Stampfer

Charles S. Fuchs

P577

2011-11-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22086883

http://www.w3.org/2001/XMLSchema#string

P932

3253914

http://www.w3.org/2001/XMLSchema#string